Cite Filings / WVE / 0001144204-19-003157
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13D/A

Beneficial Ownership Report

Wave Life Sciences, Inc. · Filed 2019-01-28 · Acc 0001144204-19-003157

Documents 1

  • SC 13D/A Beneficial Ownership Report , tv511720_sc13da.htm

Around this filing

  • 2019-02-20 SC 13D/A Beneficial Ownership Report
  • 2019-01-28 4 Director bought 263,158 shares at $38.00 ($10,000,004)
  • 2019-01-28 SC 13D/A Beneficial Ownership Report
  • 2019-01-24 8-K Material agreement · Other events
  • 2019-01-24 424B5 Prospectus
  • 2019-01-23 8-K Results of operations · Other events
  • 2018-04-26 SC 13D/A Beneficial Ownership Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Maverick Capital, Ltd. 0.0%
  2. 2024-02-13 SC 13G/A · BB Biotech AG 3.7%
  3. 2023-02-14 SC 13G/A · BB Biotech AG 5.2%
  4. 2022-02-11 SC 13G/A · BB Biotech AG 7.8%
  5. 2021-02-12 SC 13G/A · BB Biotech AG 5.3%
  6. 2020-02-14 SC 13G/A · BB Biotech AG 7.0%
  7. 2019-12-23 SC 13G · BB Biotech AG 5.5%
Loading tv511720_sc13da.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…